10x Genomics, Inc.
A life-sciences technology company that makes instruments, consumables, and software for studying biology at the level of individual cells and their spatial context, using its Chromium and Visium platforms. Founded in 2012 in Pleasanton, California, by Serge Saxonov, Ben Hindson, and Kevin Ness, the company's name reflects their goal of a ten-fold, or "10x," improvement in biological resolution rather than incremental progress.
Granted 778.2K · Sold 376.2K
Granted 4.0K
Granted 764.9K · Sold 323.8K
Granted 36.8K · Sold 50.0K
Granted 442.2K · Sold 79.5K
Granted 212.6K · Sold 33.0K
Granted 171.0K · Bought 158 · Sold 68.2K
Granted 156.6K · Bought 158 · Sold 102.9K
Granted 45.9K · Bought 40.0K
Granted 110.4K · Sold 28.2K
Granted 61.8K · Sold 6.0K
Granted 36.8K
Granted 43.2K · Sold 7.6K
Granted 36.8K · Sold 7.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Saxonov SergeChief Executive Officer, Director · 137 transactions | — | 4.40M | 778.2K | — | 376.2K |
| Roberts Bryan EDirector · 3 transactions | — | 4.29Mas of Jun 2023 | 4.0K | — | — |
| Hindson Benjamin J.See Remarks, Director · 81 transactions | +936.1% | 488.2K | 764.9K | — | 323.8K |
| Stuelpnagel John RDirector · 36 transactions | -4.3% | 368.4K | 36.8K | — | 50.0K |
| Taich AdamChief Financial Officer · 9 transactions | — | 362.7K | 442.2K | — | 79.5K |
| Mammen MathaiDirector · 5 transactions | +28741.4% | 180.3Kas of Jun 2024 | 212.6K | — | 33.0K |
| McAnear Justin J.Former Chief Financial Officer · 56 transactions | +266.3% | 143.2Kas of Aug 2024 | 171.0K | 158 | 68.2K |
| Crutchfield BradfordChief Commercial Officer · 49 transactions | +124.4% | 97.2Kas of May 2022 | 156.6K | 158 | 102.9K |
| Mateo AlanDirector · 4 transactions | — | 85.9K | 45.9K | 40.0K | — |
| Wilbur JamesChief Commercial Officer · 6 transactions | — | 83.3Kas of Nov 2023 | 110.4K | — | 28.2K |
| Kosaraju SridharDirector · 16 transactions | +302.6% | 68.3K | 61.8K | — | 6.0K |
| Popovits Kimberly JDirector · 5 transactions | +5891.2% | 37.4K | 36.8K | — | — |
| Teichmann Sarah A.Director · 4 transactions | — | 35.6K | 43.2K | — | 7.6K |
| Suliman ShehnaazDirector · 9 transactions | +4622.4% | 29.5K | 36.8K | — | 7.9K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -1.04M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.